Product Outlicensing/Co-development Opportunities

Genfit’s innovative proprietary products will shortly be available for outlicensing. We are currently gathering additional preclinical and clinical data from trials before entering into discussions with possible pharmaceutical partners to further advance our drug candidates. 

Click here for further information about Genfit's proprietary R&D programmes. 

Drug Discovery Alliance Opportunities

Genfit has a number of potential scientific collaboration proposals at target validation and screening tools development stages. We are currently looking for partners for exploratory programme opportunities, an example of which is briefly described below:

Early stage research collaboration in the field of heart disease: This heart failure research programme has been designed to identify new genes and gene pathways involved in the early development of left ventricular heart failure. Gene expression profile set up, analysis and comparison between patients with or without heart failure may be performed on myocardium tissues collected during an clinical investigational study. The most relevant genes are chosen for target validation. This programme not only proposes to identify new therapeutic targets and potential diagnostic biomarkers, but also to highlight novel molecular mechanisms in cardiomyocytes, which in turn help to understand left ventricular heart failure development in coronary patients.

To learn more about our different early stage programme opportunities, please contact  our Business Development Team.